A Study to Evaluate Efficacy and Safety of LCI699 in Participants With Essential Hypertension
Clinical trial NCT00758524 · COMPLETED
Trial details
- NCT number
- NCT00758524
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-09-11
- Primary completion
- 2009-07-02
- Enrollment
- 628
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.